Cemiplimab, CAS 1801342-60-8

Product Description: Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Michael R Migden, et al. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 2018 Jul 26;379(4):341-351./[2]Elena Burova, et al. Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice. Mol Cancer Ther. 2019 Nov;18(11):2051-2062.

CAS Number: 1801342-60-8

Molecular Weight: N/A

Compound Purity: 99.89

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99203-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99203-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK